Zhejiang Starry Pharmaceutical Co Ltd
SSE:603520
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Zhejiang Starry Pharmaceutical Co Ltd
SSE:603520
|
CN |
|
Wills Inc
TSE:4482
|
JP |
|
A
|
Automotive Stampings and Assemblies Ltd
NSE:ASAL
|
IN |
Zhejiang Starry Pharmaceutical Co Ltd
Zhejiang Starry Pharmaceutical Co., Ltd. engages in the research, development, manufacture, and sale of active ingredient and intermediate X-CT non-ionic contrast agent and fluoroquinolones series. The company is headquartered in Taizhou, Zhejiang and currently employs 1,818 full-time employees. The company went IPO on 2016-03-09. The X-ray contrast medium's major product is iohexol active pharmaceutical ingredient. Quinolone antimicrobial agents' major products are levofloxacin hydrochloride active pharmaceutical ingredient and levofloxacin hemihydrates active pharmaceutical ingredient.
Zhejiang Starry Pharmaceutical Co., Ltd. engages in the research, development, manufacture, and sale of active ingredient and intermediate X-CT non-ionic contrast agent and fluoroquinolones series. The company is headquartered in Taizhou, Zhejiang and currently employs 1,818 full-time employees. The company went IPO on 2016-03-09. The X-ray contrast medium's major product is iohexol active pharmaceutical ingredient. Quinolone antimicrobial agents' major products are levofloxacin hydrochloride active pharmaceutical ingredient and levofloxacin hemihydrates active pharmaceutical ingredient.
